ARMO BioSciences Investors

21 investors on Angel Roster list ARMO BioSciences in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and China.

Investors are matched on the company name in their portfolio, so companies that share the name ARMO BioSciences can appear together.

Investors listed
21
With verified email
43%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 ARMO BioSciences investors

The most complete profiles first. Showing 21 of 21.

  • Beth SeidenbergVerified

    Venture Capital, Incubator, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Atara Biotherapeutics, ACELYRIN, iPierian, Mango Health and 16 more

    Verified email available

  • Joshua KennedyVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Stephanie A. SirotaVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsEnterprise SoftwareInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Verified email available

  • Victor TongVerified

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Claire ChinVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • John HannonVerified

    Venture Capital, Private Equity Firm · United States

    TelecommunicationsPaymentsSemantic SearchCybersecurity

    Portfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 65 more

    Verified email available

  • Qiang XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Tom GoodrichVerified

    Venture Capital · United States

    PaymentsSemantic SearchCybersecurityDatabases

    Portfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 62 more

    Contact details available

  • Wei XuVerified

    Venture Capital · China

    Health CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Verified email available

  • Young ChungVerified

    Venture Capital, Private Equity Firm · United States

    PaymentsSemantic SearchCybersecurityDatabases

    Portfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 61 more

    Verified email available

  • Dan Zabrowski

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Fang Yang

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareInvestment ManagementChemicalLife Science

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Naveen Yalamanchi

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Nick Pliam

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Piratip Pratumsuwan

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Roderick Wong

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more

    Contact details available

  • Sabera Loughran

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareGeneticsInvestment ManagementLife Science

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Tony Nguyen

    Hedge Fund, Venture Capital, Investor · United States

    Series BAdvertisingHealth CareGeneticsInvestment Management

    Portfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more

    Contact details available

  • Weizhi (Aaron) Li

    Venture Capital, Private Equity Firm · China

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Y. Katherine Xu

    Venture Capital, Private Equity Firm · United States

    Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)

    Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more

    Contact details available

  • Joseph Zanone

    Venture Capital, Private Equity Firm · United States

    PaymentsSemantic SearchCybersecurityDatabases

    Portfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 61 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many ARMO BioSciences investors are on Angel Roster?

Angel Roster lists 21 ARMO BioSciences investors. 9 of them (43%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (21), Private Equity Firms (9) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do ARMO BioSciences investors invest in?

Among those that list a stage, the most common are Series B (8) and Early Stage Venture (6).

Where are ARMO BioSciences investors based?

Most are based in the United States (16) and China (5).

Which companies have ARMO BioSciences investors backed?

The most-backed portfolio companies among them are Equillium (9), Checkmate Pharmaceuticals (9), Neurelis (9), Bioheng (9) and Terns Pharmaceuticals (9).

How do I contact ARMO BioSciences investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.